Arnold, Hugh

A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells

Yeh, E., Cunningham, M., Arnold, H., Chasse, D., Monteith, T., Ivaldi, G., Hahn, W. C., Stukenberg, P. T., Shenolikar, S., Uchida, T., et al. (2004) · Nature Cell Biology

Signaling Pathways in DiseaseProtein Kinase Regulation and GTPase Signaling

Cited by 791

CIP2A inhibits PP2A in human malignancies

Junttila, M. R., Puustinen, P., Niemelä, M., Ahola, R., Arnold, H., Böttzauw, T., Ala-aho, R., Nielsen, C., Ivaska, J., Taya, Y., et al. (2007) · Cell

Cancer Mechanisms and TherapyProtein Tyrosine Phosphatases

Cited by 677

Protein phosphatase 2A regulatory subunit B56α associates with c-myc and negatively regulates c-myc accumulation

Arnold, H. K., & Sears, R. C. (2006) · Molecular and Cellular Biology

Protein Tyrosine PhosphatasesProtein Kinase Regulation and GTPase Signaling

Cited by 251

A tumor suppressor role for PP2A-B56α through negative regulation of c-Myc and other key oncoproteins

Arnold, H. K., & Sears, R. C. (2008) · Cancer and Metastasis Reviews

Protein Tyrosine PhosphatasesPI3K/AKT/mTOR signaling in cancer

Cited by 111

Digital expression profiles of the prostate androgen-response program

Clegg, N., Eroglu, B., Ferguson, C., Arnold, H., Moorman, A., & Nelson, P. S. (2002) · The Journal of Steroid Biochemistry and Molecular Biology

Prostate Cancer Treatment and ResearchSperm and Testicular Function

Cited by 37